BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology ...

Artificial intelligence (AI) correctly localized nearly one-third of interval cancers on retrospective evaluation of ...

Overall, research shows that dairy can lower the risk of some cancers and increase the risk of others. This is why no ...

New clinical trial results reveal gedatolisib significantly improves progression-free survival in advanced HR+/HER2– breast ...

A serious failure in breast cancer care at a hospital trust has led to 12 patients being harmed and triggered investigations ...

For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with lower all-cause mortality than dipeptidyl peptidase-4 inhibitor ...

Prasad’s departure may outline the political limits of medical skepticism in the Republican party, at least when it comes to ...

Atossa Therapeutics advances Z-endoxifen for ER+/HER2- metastatic breast cancer, receiving FDA support for dose optimization ...

Calhoun, GA, July 31, 2025-Mohawk is set to support walkers in the 2025 Susan G. Komen 3-Day Series. Starting today, the ...

Alexis Klimpl, 25, is one of a growing number of women under 40 diagnosed with breast cancer in recent years. Now, she's a ...

Findings reinforce the need for approaches to minimize the risk of awakening lung DCCs and metastatic disease in cancer survivors who develop respiratory virus infections.

In a study involving mice exposed to COVID-19, researchers found the respiratory infections triggered dormant cancer cells to wake up, setting the stage for new tumors.